X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Aurobindo Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs AUROBINDO PHARMA - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD AUROBINDO PHARMA STRIDES SHASUN LTD/
AUROBINDO PHARMA
 
P/E (TTM) x 13.5 13.7 98.6% View Chart
P/BV x 1.6 3.5 44.5% View Chart
Dividend Yield % 0.6 0.4 142.6%  

Financials

 STRIDES SHASUN LTD   AUROBINDO PHARMA
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
AUROBINDO PHARMA
Mar-17
STRIDES SHASUN LTD/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,275895 142.4%   
Low Rs918622 147.6%   
Sales per share (Unadj.) Rs389.6254.6 153.0%  
Earnings per share (Unadj.) Rs28.039.3 71.2%  
Cash flow per share (Unadj.) Rs48.946.6 105.0%  
Dividends per share (Unadj.) Rs4.502.50 180.0%  
Dividend yield (eoy) %0.40.3 124.5%  
Book value per share (Unadj.) Rs303.1160.0 189.5%  
Shares outstanding (eoy) m89.42585.88 15.3%   
Bonus/Rights/Conversions ESOPESOP-  
Price / Sales ratio x2.83.0 94.5%   
Avg P/E ratio x39.219.3 203.0%  
P/CF ratio (eoy) x22.416.3 137.7%  
Price / Book Value ratio x3.64.7 76.3%  
Dividend payout %16.16.4 252.8%   
Avg Mkt Cap Rs m98,036444,390 22.1%   
No. of employees `0005.814.0 41.5%   
Total wages/salary Rs m5,88117,678 33.3%   
Avg. sales/employee Rs Th6,005.910,667.8 56.3%   
Avg. wages/employee Rs Th1,014.01,264.3 80.2%   
Avg. net profit/employee Rs Th431.21,645.8 26.2%   
INCOME DATA
Net Sales Rs m34,834149,157 23.4%  
Other income Rs m1,6861,159 145.5%   
Total revenues Rs m36,520150,316 24.3%   
Gross profit Rs m6,42834,343 18.7%  
Depreciation Rs m1,8724,276 43.8%   
Interest Rs m2,269667 340.1%   
Profit before tax Rs m3,97330,558 13.0%   
Minority Interest Rs m050 0.0%   
Prior Period Items Rs m40-   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m4707,597 6.2%   
Profit after tax Rs m2,50123,012 10.9%  
Gross profit margin %18.523.0 80.1%  
Effective tax rate %11.824.9 47.6%   
Net profit margin %7.215.4 46.5%  
BALANCE SHEET DATA
Current assets Rs m38,16592,062 41.5%   
Current liabilities Rs m30,40266,223 45.9%   
Net working cap to sales %22.317.3 128.6%  
Current ratio x1.31.4 90.3%  
Inventory Days Days77106 73.0%  
Debtors Days Days10468 154.4%  
Net fixed assets Rs m37,63962,919 59.8%   
Share capital Rs m894586 152.6%   
"Free" reserves Rs m26,21093,133 28.1%   
Net worth Rs m27,10593,719 28.9%   
Long term debt Rs m16,3771,814 902.8%   
Total assets Rs m81,168162,494 50.0%  
Interest coverage x2.846.8 5.9%   
Debt to equity ratio x0.60 3,121.7%  
Sales to assets ratio x0.40.9 46.8%   
Return on assets %5.914.6 40.3%  
Return on equity %9.224.6 37.6%  
Return on capital %12.132.7 36.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m13,46575,838 17.8%   
Fx outflow Rs m4,07630,224 13.5%   
Net fx Rs m9,38945,613 20.6%   
CASH FLOW
From Operations Rs m2,88132,786 8.8%  
From Investments Rs m-7,051-17,870 39.5%  
From Financial Activity Rs m3,382-19,153 -17.7%  
Net Cashflow Rs m-788-4,239 18.6%  

Share Holding

Indian Promoters % 27.7 54.1 51.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.8 8.0 475.5%  
FIIs % 8.6 27.7 31.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 10.2 253.9%  
Shareholders   56,241 69,601 80.8%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   ELDER PHARMA  FDC LTD.  SHASUN PHARMA  DISHMAN PHARMA  TTK HEALTHCARE  

Compare STRIDES SHASUN LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Firm; IT Stocks Gain(09:30 am)

Asian stocks were relatively subdued in the early trade today, with most regional indices hovering around the flat line following the softer lead stateside.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Feb 21, 2018 10:55 AM

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 5-YR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS